Contact Us

New Prostate Cancer Med Extends Life by Nearly Five Months: Study

Thinkstock

A study, conducted by pharmaceutical company Astellas Pharma Europe LTD, found when compared to patients prescribed a placebo, an investigational drug extended life by almost five months in men with advanced prostate cancer who already underwent chemotherapy treatment.

MDV3100 was created by Astellas Pharma Inc. for men with advanced prostate cancer. Results from a third phase of a survey found that MDV3100 lead to a high improvement of the overall prostate cancer survival rate, and an average improvement over placebo of 4.8 months. The survey also confirmed that patients had no significant problems taking MDV3100.

A separate study also conducted by Astellas, which questioned 500 oncologists and urologists in five different European countries, showed that 99 percent of the doctors feel that there is a need for new treatment options to extend the lives of advanced stage cancer patients. The study also showed that overall survival is considered the most important attribute of a new advanced prostate cancer treatment, according to 85 percent of oncologists, and 74 percent of urologists.

“Extending patients lives at this late stage of their disease is our primary aim, but it’s incredibly important to balance this with the impact treatment may have on patient quality of life,” Axel Heidenreich, Director of the Department of Urology, at Rheinisch-Westfalische Technische Hochschule University, in Germany, said in a statement.

The data was presented at the European Association of Urology (EAU) congress in Paris, France.

More From News Talk KGVO

Best of the Web

It appears that you already have an account created within our VIP network of sites on . To keep your points and personal information safe, we need to verify that it's really you. To activate your account, please confirm your password. When you have confirmed your password, you will be able to log in through Facebook on both sites.

Forgot your password?

*Please note that your points, prizes and activities will not be shared between programs within our VIP network.

It appears that you already have an account on this site associated with . To connect your existing account with your Facebook account, just click on the account activation button below. You will maintain your existing profile and VIP program points. After you do this, you will be able to always log in to http://newstalkkgvo.com using your Facebook account.

*Please note that your points, prizes and activities will not be shared between programs within our VIP network.

Please fill out the information below to help us provide you a better experience.

Register on News Talk KGVO Radio quickly by logging in with your Facebook account. It's just as secure, and no password to remember!

Not a Member? Sign Up Here.

Sign up for an account to comment, share your thoughts, and earn points to get great prizes.

Register on News Talk KGVO Radio quickly by logging in with your Facebook account. It's just as secure, and no password to remember!